Skip to content

Development and Application of a Parenting Anxiety Intervention Program for Young and Middle-Aged Female Breast Cancer Patients

Parenting Concerns of Young and Middle-aged Women With Breast Cancer: A Study Protocol for a Feasibility Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07331740
Enrollment
20
Registered
2026-01-12
Start date
2026-03-01
Completion date
2026-12-01
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Parenting Anxiety

Keywords

Young and middle-aged female breast cancer patients, Intervention program, Feasibility trial, Parenting Anxiety

Brief summary

This feasibility study aims to develop and test an intervention program for young and middle-aged female breast cancer patients who experience parenting concerns. Eligible participants will receive the tailored support program (including psychological counseling and parenting guidance). The study will assess whether the program is acceptable, feasible, and potentially helpful in reducing parenting concerns among this group.We plan to enroll 20 participants from Shanghai Zhoupu Hospital between March 2026 and October 2026.

Interventions

BEHAVIORALParenting Concerns Support Program

A 6-week program including 2 individual psychological counseling sessions and 4 group parenting guidance activities, designed to reduce parenting concerns in young and middle-aged female breast cancer patients.

Sponsors

Shanghai University of Traditional Chinese Medicine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

This is a single-arm feasibility trial; all eligible participants receive the parenting anxiety intervention program.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 59 Years
Healthy volunteers
No

Inclusion criteria

* Clear breast cancer patients confirmed by histopathology who have received surgical treatment * Aged 18 to 59 and currently raising at least one minor child under the age of 18 * Clinical stage I - IV * Be aware of the condition, provide informed consent and voluntarily participate in this study * The patient can cooperate with the research independently and has normal reading, comprehension, thinking and judgment abilities

Exclusion criteria

* Concurrent with other cancers * Engaged in psychology work, or having received psychological intervention guidance within the past six months * Participate in other nursing intervention studies simultaneously

Design outcomes

Primary

MeasureTime frameDescription
Parenting Concerns Scale for Breast Cancer PatientsBaseline (pre-intervention) , 6 weeks post-intervention (end of the program) and One month after the intervention endedThis scale was developed by Qian Meiyan et al. in 2024 to assess the parenting anxiety level of breast cancer patients. The scale mainly consists of 5 dimensions and 25 items, namely disease communication (5 items), children's health (4 items), children's emotions (6 items), role communication (6 items), and family support (4 items).

Secondary

MeasureTime frameDescription
Parenting Sense of Competence ScaleBaseline (pre-intervention), 6 weeks post-intervention (end of the program) and One month after the intervention endedThis scale was created by Gibaud-Wallston in 1977, aiming to assess the self-perception and confidence level of caregivers.
Herth hope indexBaseline (pre-intervention) , 6 weeks post-intervention (end of the program) and One month after the intervention endedCompiled by American scholar Herth in 1991, it is applicable to the survey of hope levels among healthy or sick adults. This scale continues to consist of 3 dimensions and 12 items, namely positive attitudes towards reality and the future, taking positive actions, and maintaining close relationships with others.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026